Gossamer Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $9,238 | $16,955 | $13,799 | $13,294 |
Gross Profit | 9,238 | 16,722 | 13,799 | 13,294 |
EBITDA | -71,233 | -43,677 | -44,348 | -45,253 |
EBIT | -71,485 | -43,909 | -44,575 | -45,473 |
Net Income | 16,900 | -46,664 | -47,238 | -48,221 |
Net Change In Cash | 9,238 | 16,955 | 13,799 | 13,294 |
Free Cash Flow | -39,424 | -38,721 | -48,314 | -36,167 |
Cash | 41,148 | 41,028 | 37,732 | 8,933 |
Basic Shares | 4,109 | 2,926 | 2,832 | 2,849 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $48,471 | $114,701 | $0 | $0 |
Gross Profit | 47,469 | 114,701 | -4,385 | -4,429 |
EBITDA | -158,467 | -39,967 | -161,921 | -211,069 |
EBIT | -159,469 | -44,118 | -166,306 | -215,498 |
Net Income | -170,370 | -56,528 | -179,817 | -229,378 |
Net Change In Cash | 48,471 | 114,701 | 0 | 0 |
Cost of Revenue | -70,977 | |||
Free Cash Flow | -171,345 | -3,468 | -159,158 | -187,507 |
Cash | 37,732 | 46,074 | 32,109 | 111,973 |
Basic Shares | 2,856 | 2,827 | 1,907 | 1,057 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.20 |
2026-03-31 | -$0.20 |
2025-12-31 | -$0.21 |
2025-09-30 | -$0.21 |